Delivery Order SPE2DB22D3011-SPE2DB25FP7QB
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,086,434 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,997.58 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 8, 2024, with a completion date of July 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corporation's Corporate Office division is for the delivery of 4,565,463,591 units of the Boostrix TDAP vaccine syringe (0.5 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,061.60 firm-fixed-price delivery order was issued under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA for providing a comprehensive range of medical commodities to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccines in 0.5 mL syringes. The contract has a firm fixed price of $2,554.30 and a completion date of May 28, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,564,857,040 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) to the Defense Logistics Agency (DLA). The $2,783.88 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the U.S. government. The award has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) by the Defense Logistics Agency (DLA) is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5mL). The contract, valued at $1,031.16, is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. The contract is not designated with a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $1,031.16 and a period of performance through July 1, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Boostrix TDAP vaccine syringes. The contract has a firm fixed price of $96,089.60 and a period of performance through March 6, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,098.40 firm fixed-price delivery order is for the supply of 4,561,082,760 Boostrix TDAP vaccine syringes, with a performance period through May 31, 2023. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,427.58, is for the delivery of 4,567,957,139 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,612.30 fixed-price delivery order contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...